<i>TPX2</i> overexpression promotes sensitivity to dasatinib in breast cancer by activating <scp>YAP</scp> transcriptional signaling
Carlos Marugán(Instituto de Investigaciones Biomédicas Sols-Morreale), Guillermo de Cárcer(Spanish National Cancer Research Centre)
Cited by 5
Related Papers
Plk1 overexpression induces chromosomal instability and suppresses tumor development
|Nature Communications|2018|165
TPX2 expression promotes sensitivity to dasatinib in breast cancer by activating the YAP transcriptional signaling
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0